Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Long Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be used for a number of different types of diabetes.
This report elaborates on the current development of the Long Acting Insulins industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Novo Nordisk A/S
Biocon Limited
Eli Lilly and Company
Pfizer Inc
By Type:
Insulin Glargine
Long Acting Animal Insulin
Insulin Degludec
Insulin Determir
By Application:
Others
Home Use
Medical Institutions
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Long Acting Insulins Market Overview 2018-2029
-
1.1 China Long Acting Insulins Industry Development Overview
-
1.2 China Long Acting Insulins Industry Development History
-
1.3 China Long Acting Insulins Industry Market Size (2018-2029)
-
1.4 China Long Acting Insulins Market Analysis by Type from Production Side
-
1.4.1 China Long Acting Insulins Production Volume, Production Value and Growth Rate of Insulin Glargine (2018-2029)
-
1.4.2 China Long Acting Insulins Production Volume, Production Value and Growth Rate of Long Acting Animal Insulin (2018-2029)
-
1.4.3 China Long Acting Insulins Production Volume, Production Value and Growth Rate of Insulin Degludec (2018-2029)
-
1.4.4 China Long Acting Insulins Production Volume, Production Value and Growth Rate of Insulin Determir (2018-2029)
-
1.5 China Long Acting Insulins Market Analysis by Application from Consumption End
-
1.5.1 China Long Acting Insulins Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.2 China Long Acting Insulins Sales Volume, Sales Value and Growth Rate of Home Use (2018-2029)
-
1.5.3 China Long Acting Insulins Sales Volume, Sales Value and Growth Rate of Medical Institutions (2018-2029)
-
1.6 China Long Acting Insulins Market Analysis by Region
-
1.6.1 North China Long Acting Insulins Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Long Acting Insulins Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Long Acting Insulins Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Long Acting Insulins Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Long Acting Insulins Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Long Acting Insulins Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Long Acting Insulins Market Size and Growth Rate from 2018-2029
Chapter 2 China Long Acting Insulins Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Long Acting Insulins Market Status and Competition at home and abroad in 2023
-
2.2.2 China Long Acting Insulins Market Status and Competition Analysis in 2023
-
2.2.3 China Long Acting Insulins Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Long Acting Insulins Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Long Acting Insulins Industry Development
Chapter 3 Long Acting InsulinsIndustry Chain Analysis
-
3.1 Long Acting Insulins Industry Chain
-
3.2 Long Acting Insulins Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Long Acting Insulins Market
-
3.3 Long Acting Insulins Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Long Acting Insulins Market
Chapter 4 China Long Acting Insulins Market, by Type
-
4.1 China Long Acting Insulins Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Long Acting Insulins Total Production Volume and Growth Rate from Production Side
-
4.5 China Long Acting Insulins Production Volume and Growth Rate, by Type
-
4.5.1 China Long Acting Insulins Production Volume and Growth Rate of Insulin Glargine
-
4.5.2 China Long Acting Insulins Production Volume and Growth Rate of Long Acting Animal Insulin
-
4.5.3 China Long Acting Insulins Production Volume and Growth Rate of Insulin Degludec
-
4.5.4 China Long Acting Insulins Production Volume and Growth Rate of Insulin Determir
Chapter 5 China Long Acting Insulins Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Long Acting Insulins Total Market Size and Growth Rate from Consumption End
-
5.5 China Long Acting Insulins Market Size and Growth Rate, by Application
-
5.5.1 China Long Acting Insulins Market Size and Growth Rate of Others
-
5.5.2 China Long Acting Insulins Market Size and Growth Rate of Home Use
-
5.5.3 China Long Acting Insulins Market Size and Growth Rate of Medical Institutions
Chapter 6 China Long Acting Insulins Market, by Region
-
6.1 China Long Acting Insulins Production Volume and Production Value, by Region
-
6.2 China Long Acting Insulins Sales Volume and Sales Value, by Region
Chapter 7 North China Long Acting Insulins Market Analysis
-
7.1 North China Long Acting Insulins Market, by Type
-
7.2 North China Long Acting Insulins Market, by Application
Chapter 8 Central China Long Acting Insulins Market Analysis
-
8.1 Central China Long Acting Insulins Market, by Type
-
8.2 Central China Long Acting Insulins Market, by Application
Chapter 9 South China Long Acting Insulins Market Analysis
-
9.1 South China Long Acting Insulins Market, by Type
-
9.2 South China Long Acting Insulins Market, by Application
Chapter 10 East China Long Acting Insulins Market Analysis
-
10.1 East China Long Acting Insulins Market, by Type
-
10.2 East China Long Acting Insulins Market, by Application
Chapter 11 Northeast China Long Acting Insulins Market Analysis
-
11.1 Northeast China Long Acting Insulins Market, by Type
-
11.2 Northeast China Long Acting Insulins Market, by Application
Chapter 12 Southwest China Long Acting Insulins Market Analysis
-
12.1 Southwest China Long Acting Insulins Market, by Type
-
12.2 Southwest China Long Acting Insulins Market, by Application
Chapter 13 Northwest China Long Acting Insulins Market Analysis
-
13.1 Northwest China Long Acting Insulins Market, by Type
-
13.2 Northwest China Long Acting Insulins Market, by Application
Chapter 14 Company Profiles
-
14.1 Novo Nordisk A/S
-
14.1.1 Novo Nordisk A/S Company Profile
-
14.1.2 Novo Nordisk A/S Long Acting Insulins Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Biocon Limited
-
14.2.1 Biocon Limited Company Profile
-
14.2.2 Biocon Limited Long Acting Insulins Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Eli Lilly and Company
-
14.3.1 Eli Lilly and Company Company Profile
-
14.3.2 Eli Lilly and Company Long Acting Insulins Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Pfizer Inc
-
14.4.1 Pfizer Inc Company Profile
-
14.4.2 Pfizer Inc Long Acting Insulins Market Performance
-
14.4.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Long Acting Insulins Industry Research Conclusions
-
15.2 Long Acting Insulins Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Long Acting Insulins Industry Market Size (2018-2029)
-
Figure China Long Acting Insulins Production Volume, Production Value and Growth Rate of Insulin Glargine (2018-2029)
-
Figure China Long Acting Insulins Production Volume, Production Value and Growth Rate of Long Acting Animal Insulin (2018-2029)
-
Figure China Long Acting Insulins Production Volume, Production Value and Growth Rate of Insulin Degludec (2018-2029)
-
Figure China Long Acting Insulins Production Volume, Production Value and Growth Rate of Insulin Determir (2018-2029)
-
Figure China Long Acting Insulins Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Long Acting Insulins Sales Volume, Sales Value and Growth Rate of Home Use (2018-2029)
-
Figure China Long Acting Insulins Sales Volume, Sales Value and Growth Rate of Medical Institutions (2018-2029)
-
Figure North China Long Acting Insulins Market Size and Growth Rate from 2018-2029
-
Figure Central China Long Acting Insulins Market Size and Growth Rate from 2018-2029
-
Figure South China Long Acting Insulins Market Size and Growth Rate from 2018-2029
-
Figure East China Long Acting Insulins Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Long Acting Insulins Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Long Acting Insulins Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Long Acting Insulins Market Size and Growth Rate from 2018-2029
-
Figure Long Acting Insulins Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Long Acting Insulins Market Share by Type in 2018
-
Figure China Long Acting Insulins Market Share by Type in 2023
-
Figure China Long Acting Insulins Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Long Acting Insulins Production Volume and Growth Rate of Insulin Glargine (2018-2023)
-
Figure China Long Acting Insulins Production Volume and Growth Rate of Long Acting Animal Insulin (2018-2023)
-
Figure China Long Acting Insulins Production Volume and Growth Rate of Insulin Degludec (2018-2023)
-
Figure China Long Acting Insulins Production Volume and Growth Rate of Insulin Determir (2018-2023)
-
Figure China Long Acting Insulins Market Share by Application in 2018
-
Figure China Long Acting Insulins Market Share by Application in 2023
-
Figure China Long Acting Insulins Total Market Size and Growth Rate from Consumption End
-
Figure China Long Acting Insulins Market Size and Growth Rate of Others (2018-2023)
-
Figure China Long Acting Insulins Market Size and Growth Rate of Home Use (2018-2023)
-
Figure China Long Acting Insulins Market Size and Growth Rate of Medical Institutions (2018-2023)
-
Table China Long Acting Insulins Production Volume by Region (2018-2023)
-
Table China Long Acting Insulins Production Volume Share by Region (2018-2023)
-
Figure China Long Acting Insulins Production Volume Share by Region (2018-2023)
-
Table China Long Acting Insulins Production Value by Region (2018-2023)
-
Table China Long Acting Insulins Production Value Share by Region (2018-2023)
-
Figure China Long Acting Insulins Production Value Share by Region (2018-2023)
-
Table China Long Acting Insulins Sales Volume by Region (2018-2023)
-
Table China Long Acting Insulins Sales Volume Share by Region (2018-2023)
-
Figure China Long Acting Insulins Sales Volume Share by Region (2018-2023)
-
Table China Long Acting Insulins Sales Value by Region (2018-2023)
-
Table China Long Acting Insulins Sales Value Share by Region (2018-2023)
-
Figure China Long Acting Insulins Sales Value Share by Region (2018-2023)
-
Table North China Long Acting Insulins Production Volume by Type (2018-2023)
-
Table North China Long Acting Insulins Production Volume Share by Type (2018-2023)
-
Figure North China Long Acting Insulins Production Volume Share by Type (2018-2023)
-
Table North China Long Acting Insulins Sales Volume by Application (2018-2023)
-
Table North China Long Acting Insulins Sales Volume Share by Application (2018-2023)
-
Figure North China Long Acting Insulins Sales Volume Share by Application (2018-2023)
-
Table Central China Long Acting Insulins Production Volume by Type (2018-2023)
-
Table Central China Long Acting Insulins Production Volume Share by Type (2018-2023)
-
Figure Central China Long Acting Insulins Production Volume Share by Type (2018-2023)
-
Table Central China Long Acting Insulins Sales Volume by Application (2018-2023)
-
Table Central China Long Acting Insulins Sales Volume Share by Application (2018-2023)
-
Figure Central China Long Acting Insulins Sales Volume Share by Application (2018-2023)
-
Table South China Long Acting Insulins Production Volume by Type (2018-2023)
-
Table South China Long Acting Insulins Production Volume Share by Type (2018-2023)
-
Figure South China Long Acting Insulins Production Volume Share by Type (2018-2023)
-
Table South China Long Acting Insulins Sales Volume by Application (2018-2023)
-
Table South China Long Acting Insulins Sales Volume Share by Application (2018-2023)
-
Figure South China Long Acting Insulins Sales Volume Share by Application (2018-2023)
-
Table East China Long Acting Insulins Production Volume by Type (2018-2023)
-
Table East China Long Acting Insulins Production Volume Share by Type (2018-2023)
-
Figure East China Long Acting Insulins Production Volume Share by Type (2018-2023)
-
Table East China Long Acting Insulins Sales Volume by Application (2018-2023)
-
Table East China Long Acting Insulins Sales Volume Share by Application (2018-2023)
-
Figure East China Long Acting Insulins Sales Volume Share by Application (2018-2023)
-
Table Northeast China Long Acting Insulins Production Volume by Type (2018-2023)
-
Table Northeast China Long Acting Insulins Production Volume Share by Type (2018-2023)
-
Figure Northeast China Long Acting Insulins Production Volume Share by Type (2018-2023)
-
Table Northeast China Long Acting Insulins Sales Volume by Application (2018-2023)
-
Table Northeast China Long Acting Insulins Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Long Acting Insulins Sales Volume Share by Application (2018-2023)
-
Table Southwest China Long Acting Insulins Production Volume by Type (2018-2023)
-
Table Southwest China Long Acting Insulins Production Volume Share by Type (2018-2023)
-
Figure Southwest China Long Acting Insulins Production Volume Share by Type (2018-2023)
-
Table Southwest China Long Acting Insulins Sales Volume by Application (2018-2023)
-
Table Southwest China Long Acting Insulins Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Long Acting Insulins Sales Volume Share by Application (2018-2023)
-
Table Northwest China Long Acting Insulins Production Volume by Type (2018-2023)
-
Table Northwest China Long Acting Insulins Production Volume Share by Type (2018-2023)
-
Figure Northwest China Long Acting Insulins Production Volume Share by Type (2018-2023)
-
Table Northwest China Long Acting Insulins Sales Volume by Application (2018-2023)
-
Table Northwest China Long Acting Insulins Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Long Acting Insulins Sales Volume Share by Application (2018-2023)
-
Table Novo Nordisk A/S Company Profile
-
Table Novo Nordisk A/S Long Acting Insulins Revenue, Price and Gross (2018-2023)
-
Table Biocon Limited Company Profile
-
Table Biocon Limited Long Acting Insulins Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly and Company Company Profile
-
Table Eli Lilly and Company Long Acting Insulins Revenue, Price and Gross (2018-2023)
-
Table Pfizer Inc Company Profile
-
Table Pfizer Inc Long Acting Insulins Revenue, Price and Gross (2018-2023)
-
